Literature DB >> 8703641

Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue.

R C Freeman1, G M Rodriguez, J F French.   

Abstract

Although treatment with zidovudine (AZT) is now recommended for asymptomatic and symptomatic HIV-infected persons with CD4+ cell counts of 0.20 to 0.50 x 10(9)/L and under, data gathered from a small convenience sample of current and former injection drug users with AIDS in the New York City metropolitan region suggest that noncompliance with HIV/AIDS-related therapeutic regimen may be common in this population. This paper enumerates the reasons for noncompliance offered by these informants, reviews the general literature on treatment compliance to identify additional potential reasons for non-adherence to AZT treatment regimen, and outlines some suggestions for future research into this important issue that may prompt changes in the antiviral delivery system.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8703641

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN： 0899-9546


  10 in total

1.  When should we delay highly active antiretroviral therapy?

Authors:  D R Bangsberg; A Moss
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

2.  The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women.

Authors:  Daniel J Feaster; Ahnalee M Brincks; Victoria B Mitrani; Guillermo Prado; Seth J Schwartz; Jose Szapocznik
Journal:  J Fam Psychol       Date:  2010-02

3.  Risk factors for kidney disease among HIV-1 positive persons in the methadone program.

Authors:  Bartłomiej Matłosz; Ewa Pietraszkiewicz; Ewa Firląg-Burkacka; Ewa Grycner; Andrzej Horban; Justyna D Kowalska
Journal:  Clin Exp Nephrol       Date:  2018-09-14       Impact factor: 2.801

4.  An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community.

Authors:  Olga Grinstead Reznick; Kathleen McCartney; Steven E Gregorich; Barry Zack; Daniel J Feaster
Journal:  J Correct Health Care       Date:  2013-05-08

5.  Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Authors:  James L Sorensen; Nancy A Haug; Kevin L Delucchi; Valerie Gruber; Evan Kletter; Steven L Batki; Jacqueline P Tulsky; Paul Barnett; Sharon Hall
Journal:  Drug Alcohol Depend       Date:  2006-10-23       Impact factor: 4.492

6.  Relationships over time between mental health symptoms and transmission risk among persons living with HIV.

Authors:  W Scott Comulada; Mary Jane Rotheram-Borus; Willo Pequegnat; Robert E Weiss; Katherine A Desmond; Elizabeth Mayfield Arnold; Robert H Remien; Stephen F Morin; Lance S Weinhardt; Mallory O Johnson; Margaret A Chesney
Journal:  Psychol Addict Behav       Date:  2010-03

7.  A new paradigm for HIV care: ethical and clinical considerations.

Authors:  S Noring; N N Dubler; G Birkhead; B Agins
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

8.  Adjustment of Adolescents of Parents Living with HIV.

Authors:  Nancy Wu; Suzanne Slocum; Scott Comulada; Patricia Lester; Alan Semaan; Mary Jane Rotheram-Borus
Journal:  J HIV AIDS Prev Child Youth       Date:  2008

9.  A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.

Authors:  Perry N Halkitis; Joseph Palamar
Journal:  J Gay Lesbian Soc Serv       Date:  2008

10.  Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada.

Authors:  Alexandra B Collins; Surita Parashar; Robert S Hogg; Saranee Fernando; Catherine Worthington; Patrick McDougall; Rosalind Baltzer Turje; Ryan McNeil
Journal:  J Int AIDS Soc       Date:  2017-03-03       Impact factor: 5.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.